Ultragenyx Pharmaceutical RARE
$16.48 −$0.74 (-4.30%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $16.50 +0.12%
Open$16.94
Prev close$17.22
Day range$16.43 – $17.35
Volume3.01M
Market cap$1.68B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts19
Average target$25.39+54.1% vs. price
- Buy 47%
- Hold 53%
Low $16.00Now $16.48Avg $25.39High $39.00
Recent rating changes
The last 20 actions on file set price targets from $16.00 to $39.00, averaging $25.15.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 6 Nov 2026 | Citi | BUY | $22.00 |
| 6 Nov 2026 | H.C. Wainwright | BUY | $25.00 |
| 5 Nov 2026 | Piper Sandler | BUY | $36.00 |
| 5 Nov 2026 | Citi | BUY | $22.00 |
| 5 Nov 2026 | Leerink Partners | BUY | $33.00 |
| 5 Nov 2026 | H.C. Wainwright | BUY | $25.00 |
| 5 Nov 2026 | Barclays | BUY | $32.00 |
| 4 Nov 2026 | TD Cowen | BUY | $19.00 |
| 4 Nov 2026 | CCORF | BUY | $34.00 |
| 4 Nov 2026 | BofA Securities | HOLD | $20.00 |
| 4 Nov 2026 | Wedbush | HOLD | $22.00 |
| 4 Nov 2026 | Morgan Stanley | HOLD | $22.00 |
| 4 Nov 2026 | Goldman Sachs | HOLD | $17.00 |
| 4 Nov 2026 | RBC Capital | HOLD | $19.00 |
| 3 Nov 2026 | Cantor Fitzgerald | BUY | $39.00 |
| 3 Nov 2026 | Wells Fargo | HOLD | $19.00 |
| 3 Nov 2026 | BofA Securities | HOLD | $20.00 |
| 21 Oct 2026 | Piper Sandler | BUY | $36.00 |
| 15 Oct 2026 | UBS | HOLD | $16.00 |
| 15 Oct 2026 | H.C. Wainwright | BUY | $25.00 |
No comments yet — be the first to weigh in on RARE.
Sign in to join the discussion.